Literature DB >> 19108888

In vitro biology of human myeloid leukemia.

Hector Mayani1, Eugenia Flores-Figueroa, Antonieta Chávez-González.   

Abstract

For about 40 years, the biology of human myeloid leukemia (ML) has been studied in different in vitro systems. Throughout this time, semisolid colony assays, Dexter-type long-term cultures and liquid suspension cultures have contributed to our understanding of the mechanisms involved in the origin and progression of this hematological disorder. By using such systems, it has been possible to identify the cells in which leukemia originates; to recognize a functional hierarchy within the hematopoietic system of leukemia patients; to identify factors, soluble and cell-associated, that regulate leukemic growth; and to study the effects of different antineoplastic drugs. Furthermore, in vitro systems for purging of leukemic cells have been developed. Still, many questions and problems remain unsolved regarding the biology of myeloid leukemia in vitro. This article presents a comprehensive review on the behavior of leukemic stem and progenitor cells, both from acute and chronic myeloid leukemia, in the different culture systems mentioned above.

Entities:  

Mesh:

Year:  2008        PMID: 19108888     DOI: 10.1016/j.leukres.2008.11.011

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  8 in total

1.  Identification of small molecules that support human leukemia stem cell activity ex vivo.

Authors:  Caroline Pabst; Jana Krosl; Iman Fares; Geneviève Boucher; Réjean Ruel; Anne Marinier; Sébastien Lemieux; Josée Hébert; Guy Sauvageau
Journal:  Nat Methods       Date:  2014-02-23       Impact factor: 28.547

2.  Prognostic importance of single-nucleotide polymorphisms in IL-6, IL-10, TGF-β1, IFN-γ, and TNF-α genes in chronic phase chronic myeloid leukemia.

Authors:  Mustafa Pehlivan; Handan Haydaroglu Sahin; Sacide Pehlivan; Kursat Ozdilli; Leylagul Kaynar; Fatma Savran Oguz; Tugce Sever; Mehmet Yilmaz; Bulent Eser; Yeliz Duvarci Ogret; Cem Kis; Vahap Okan; Mustafa Cetin; Mahmut Carin
Journal:  Genet Test Mol Biomarkers       Date:  2014-05-12

3.  Identification of candidate small-molecule therapeutics to cancer by gene-signature perturbation in connectivity mapping.

Authors:  Darragh G McArt; Shu-Dong Zhang
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

4.  Leptin reverts pro-apoptotic and antiproliferative effects of α-linolenic acids in BCR-ABL positive leukemic cells: involvement of PI3K pathway.

Authors:  Aurore Beaulieu; Géraldine Poncin; Zakia Belaid-Choucair; Chantal Humblet; Gordana Bogdanovic; Georges Lognay; Jacques Boniver; Marie-Paule Defresne
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

5.  Global gene expression profiles of hematopoietic stem and progenitor cells from patients with chronic myeloid leukemia: the effect of in vitro culture with or without imatinib.

Authors:  Sócrates Avilés-Vázquez; Antonieta Chávez-González; Alfredo Hidalgo-Miranda; Dafne Moreno-Lorenzana; Lourdes Arriaga-Pizano; Miguel Á Sandoval-Esquivel; Manuel Ayala-Sánchez; Rafael Aguilar; Luis Alfaro-Ruiz; Hector Mayani
Journal:  Cancer Med       Date:  2017-10-13       Impact factor: 4.452

6.  Role of physical function in predicting short-term treatment outcome in Egyptian acute myeloid leukemia patients: a single center experience.

Authors:  Mohamed A Fateen; Doaa M El Demerdash; Rania A Zayed; Mervat M Mattar
Journal:  Hematol Transfus Cell Ther       Date:  2018-06-14

Review 7.  Isolation, Maintenance and Expansion of Adult Hematopoietic Stem/Progenitor Cells and Leukemic Stem Cells.

Authors:  Isabella Maria Mayer; Andrea Hoelbl-Kovacic; Veronika Sexl; Eszter Doma
Journal:  Cancers (Basel)       Date:  2022-03-28       Impact factor: 6.639

8.  Development of a pneumatically driven active cover lid for multi-well microplates for use in perfusion three-dimensional cell culture.

Authors:  Song-Bin Huang; Dean Chou; Yu-Han Chang; Ke-Cing Li; Tzu-Keng Chiu; Yiannis Ventikos; Min-Hsien Wu
Journal:  Sci Rep       Date:  2015-12-16       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.